Pharmacycle: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharmacycle
Largest movements
- Current investments -€38,156
down €38,156 (-74.5%), from €51,233 to €13,077
- Cash -€9,283
down €9,283 (-77.3%), from €12,014 to €2,731
mainly Other debts (-€44,580) and Contributions, distributions and other (-€5,640)
- Tangible fixed assets -€3,041
down €3,041 (-32.0%), from €9,514 to €6,473
of which Furniture and vehicles: -€2,862
- Other debts -€44,580
down €44,580 (-88.8%), from €50,220 to €5,640
- Tax, wage and social debts -€3,632
down €3,632 (-41.4%), from €8,774 to €5,143
- Debts after one year -€928
no longer reported in 2025 (was €928)
- Gross operating margin -€45,225
down €45,225 (-81.0%), from €55,865 to €10,640
- Taxes -€12,296
down €12,296 (-87.2%), from €14,105 to €1,810
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €91,392 | €41,191 | -€50,201 | -54.9% |
| Fixed assets | 21/28 | €9,514 | €6,473 | -€3,041 | -32.0% |
| Tangible fixed assets | 22/27 | €9,514 | €6,473 | -€3,041 | -32.0% |
| Plant, machinery and equipment | 23 | €1,785 | €1,606 | -€179 | -10.0% |
| Furniture and vehicles | 24 | €7,730 | €4,868 | -€2,862 | -37.0% |
| Current assets | 29/58 | €81,878 | €34,718 | -€47,160 | -57.6% |
| Amounts receivable within one year | 40/41 | €18,056 | €18,288 | +€232 | +1.3% |
| Trade receivables | 40 | €8,730 | €10,532 | +€1,802 | +20.6% |
| Other amounts receivable | 41 | €9,326 | €7,756 | -€1,570 | -16.8% |
| Current investments | 50/53 | €51,233 | €13,077 | -€38,156 | -74.5% |
| Cash at bank and in hand | 54/58 | €12,014 | €2,731 | -€9,283 | -77.3% |
| Deferred charges and accrued income | 490/1 | €576 | €622 | +€46 | +8.0% |
| Total equity and liabilities | 10/49 | €91,392 | €41,191 | -€50,201 | -54.9% |
| Equity | 10/15 | €29,178 | €29,178 | = | 0.0% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €27,178 | €27,178 | = | 0.0% |
| Distributable reserves | 133 | €27,178 | €27,178 | = | 0.0% |
| Amounts payable | 17/49 | €62,214 | €12,013 | -€50,201 | -80.7% |
| Amounts payable after more than one year | 17 | €928 | - | -€928 | |
| Financial debts | 170/4 | €928 | - | -€928 | |
| Amounts payable within one year | 42/48 | €61,287 | €12,013 | -€49,273 | -80.4% |
| Current portion of amounts payable after more than one year | 42 | €1,530 | €928 | -€602 | -39.4% |
| Trade debts | 44 | €762 | €303 | -€459 | -60.3% |
| Suppliers | 440/4 | €762 | €303 | -€459 | -60.3% |
| Taxes, remuneration and social security | 45 | €8,774 | €5,143 | -€3,632 | -41.4% |
| Taxes | 450/3 | €8,774 | €5,143 | -€3,632 | -41.4% |
| Other amounts payable | 47/48 | €50,220 | €5,640 | -€44,580 | -88.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,180 | €3,041 | -€139 | -4.4% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €55,865 | €10,640 | -€45,225 | -81.0% |
| Operating profit (loss) | 9901 | €52,298 | €7,199 | -€45,099 | -86.2% |
| Financial income | 75/76B | €817 | €540 | -€277 | -33.9% |
| Recurring financial income | 75 | €817 | €540 | -€277 | -33.9% |
| Financial charges | 65/66B | €206 | €290 | +€84 | +40.9% |
| Recurring financial charges | 65 | €206 | €290 | +€84 | +40.9% |
| Profit (loss) for the period before taxes | 9903 | €52,909 | €7,450 | -€45,460 | -85.9% |
| Income taxes | 67/77 | €14,105 | €1,810 | -€12,296 | -87.2% |
| Profit (loss) for the period | 9904 | €38,804 | €5,640 | -€33,164 | -85.5% |
| Profit (loss) for the period to be appropriated | 9905 | €38,804 | €5,640 | -€33,164 | -85.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.